#1 Clinical Trials Search in Europe

Betula Alba Pollen Extract

Recent clinical trials are investigating the use of Betula Alba Pollen Extract, commonly known as birch pollen extract, in the treatment of allergies. These studies aim to assess the efficacy and safety of sublingual immunotherapy for patients suffering from birch pollen allergy and moderate-to-severe allergic rhinitis or rhinoconjunctivitis. The trials focus on determining the most effective and best-tolerated dose of the medication, evaluating its impact on symptoms and quality of life for allergy sufferers.

Table of Contents

What is Betula Alba Pollen Extract?

Betula Alba Pollen Extract is a substance derived from birch tree pollen. It is used in various medical products, including solutions for skin-prick tests and nasal sprays for allergy treatment[1]. This extract is being studied as a potential treatment for people who suffer from birch pollen allergies.

Medical Conditions Treated

The primary condition treated with Betula Alba Pollen Extract is moderate-to-severe allergic rhinitis or rhinoconjunctivitis caused by birch pollen[1]. These terms might sound complicated, so let’s break them down:

  • Allergic rhinitis: This is the medical term for hay fever, which causes symptoms like sneezing, runny nose, and nasal congestion.
  • Rhinoconjunctivitis: This condition affects both the nose and eyes, causing symptoms like itchy, watery eyes in addition to nasal symptoms.

These allergies are specifically related to birch pollen and must have been present for at least two years to be considered for this treatment[1].

How It Works

Betula Alba Pollen Extract is used in a treatment called sublingual immunotherapy (SLIT)[1]. Here’s how it works:

  1. The extract is given as a spray under the tongue.
  2. Regular exposure to small amounts of the allergen (birch pollen) helps the immune system become less sensitive over time.
  3. This can lead to a reduction in allergy symptoms when exposed to birch pollen in the environment.

Administration and Dosage

The extract is typically administered in two forms:

  • Nasal spray: Used for nasal provocation tests, with a maximum daily dose of 1 ml and a maximum total dose of 1.6 ml over a 2-day period[1].
  • Skin-prick test solution: Applied topically, with a maximum dose of 1 drop[1].

The exact dosage for treatment is still being studied in clinical trials to determine the most effective and best-tolerated dose[1].

Effectiveness

The effectiveness of Betula Alba Pollen Extract is currently being evaluated in clinical trials. Researchers are looking at several measures to determine how well it works:

  • Combined Symptom and Medication Score (CSMS): This score measures both the severity of allergy symptoms and the amount of medication needed to control them[1].
  • Quality of life: Researchers are using questionnaires to assess how the treatment affects patients’ overall well-being and daily activities[1].
  • Symptom-free days: The number of days without allergy symptoms or need for medication is being tracked[1].

Safety and Side Effects

While the full safety profile is still being studied, some potential side effects and safety concerns include:

  • Reactions at the site of administration (mouth or nose)
  • Potential for allergic reactions
  • Interactions with other medications or medical conditions

It’s important to note that safety is a key focus of the ongoing clinical trials[1].

Who Can Use This Treatment?

The treatment is being studied in adults aged 18-65 who meet specific criteria, including:

  • Confirmed birch pollen allergy through skin prick tests and blood tests
  • Moderate to severe allergy symptoms
  • No history of severe allergic reactions to immunotherapy
  • No severe asthma or other serious health conditions

There are also several exclusion criteria, such as pregnancy, certain medical conditions, and use of specific medications[1].

Ongoing Research

Betula Alba Pollen Extract is currently being studied in Phase II-III clinical trials. These studies aim to:

  • Determine the most effective dose
  • Assess the safety and tolerability of different doses
  • Measure the impact on allergy symptoms and quality of life
  • Evaluate long-term effectiveness

The results of these trials will help determine if this treatment becomes more widely available for people with birch pollen allergies[1].

Aspect Details
Study Type Phase II-III clinical trials
Main Objective Assess efficacy and safety of sublingual immunotherapy with Betula Alba Pollen Extract
Target Condition Moderate-to-severe allergic rhinitis/rhinoconjunctivitis due to birch pollen
Primary Endpoint Differences in Combined Symptom and Medication Score (CSMS) during peak pollen period
Key Inclusion Criteria Adults 18-65, birch pollen allergy for 2+ years, positive skin prick test and IgE levels
Key Exclusion Criteria Recent immunotherapy, severe asthma, serious systemic reactions to immunotherapy
Treatment Form Sublingual spray or solution
Secondary Outcomes Quality of life, symptom-free days, nasal provocation test results

FAQ

  • What is Betula Alba Pollen Extract? Betula Alba Pollen Extract is derived from birch tree pollen and is being studied as a potential treatment for birch pollen allergies. It is used in sublingual immunotherapy, which involves administering the allergen under the tongue to help build tolerance.
  • What conditions are being targeted in these clinical trials? The clinical trials are primarily focusing on moderate-to-severe allergic rhinitis or rhinoconjunctivitis caused by birch pollen. Some studies also include patients with well-controlled mild-to-moderate asthma.
  • How is the effectiveness of the treatment measured? The primary measure of effectiveness is the Combined Symptom and Medication Score (CSMS) during the peak birch pollen period. This score takes into account both the severity of allergy symptoms and the use of rescue medications.
  • What are some of the inclusion criteria for participants? Participants must be between 18 and 65 years old, have a history of birch pollen allergy for at least two years, show positive skin prick tests and specific IgE levels to birch pollen, and have moderate-to-severe symptoms according to established guidelines.
  • Are there any notable exclusion criteria? Key exclusion criteria include previous immunotherapy with birch pollen extracts in the last 5 years, severe or uncontrolled asthma, serious systemic reactions to immunotherapy in the past, and certain immune system disorders or severe medical conditions.

Ongoing Clinical Trials on Betula Alba Pollen Extract

  • Study on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Sublingual Immunotherapy (SLIT): A form of allergy treatment where an allergen is placed under the tongue to help the body build tolerance to the substance.
  • Allergic Rhinitis: An allergic inflammation of the nasal airways, characterized by symptoms such as sneezing, runny nose, and nasal congestion.
  • Rhinoconjunctivitis: A combination of rhinitis (nasal symptoms) and conjunctivitis (eye symptoms) often caused by allergies.
  • Combined Symptom and Medication Score (CSMS): A measure used in allergy studies that takes into account both the severity of allergy symptoms and the use of rescue medications.
  • Peak Birch Pollen Period (PBPP): The time during which birch pollen concentrations are at their highest levels in the air.
  • Forced Expiratory Volume (FEV1): A measure of lung function that represents the volume of air a person can forcefully exhale in one second.
  • Skin Prick Test: An allergy test where small amounts of allergens are pricked into the skin to check for allergic reactions.
  • Nasal Provocation Test: A test where allergens are applied to the nasal passages to diagnose and assess the severity of allergic rhinitis.
  • IgE (Immunoglobulin E): An antibody that plays a crucial role in allergic responses and is often measured to diagnose specific allergies.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-sublingual-immunotherapy-with-betula-pendula-pollen-extract-for-patients-with-birch-pollen-allergy/